• SENSEX 74,442.21
    -339.55 (--0.45%)
  • BANKNIFTY 56,606.55
    134.60 (+0.24%)
  • HDFC Bank
    730.30 1,020.35(%)
  • Solar Industries
    19,273.75 11,641.10(%)
  • Raymond
    1,121.80 1,024.00(%)
  • Zensar Tech.
    479.80 868.50(%)
  • Infosys
    1,097.40 1,727.85(%)
  • Tata Inv.Corpn.
    750.30 1,184.00(%)
  • ESDS Software
    1,802.15 1,716.35(%)
  • Reliance Industries
    1,248.50 1,250.55(%)
  • TCS
    2,322.50 3,336.70(%)
  • Pine Labs
    191.50 134.75(%)
  • Hero Motocorp
    5,325.55 6,390.00(%)
  • Gland Pharma
    2,867.95 1,575.00(%)
  • Netweb Technol.
    4,654.00 2,820.80(%)
  • SBI
    978.00 816.25(%)
  • JSW Holdings
    10,990.00 10,500.05(%)
  • Bharat Electron
    387.65 380.35(%)
  • Cummins India
    4,930.00 3,802.55(%)
  • Coforge
    1,776.00 1,008.50(%)
  • HCL Technologies
    1,290.10 1,770.00(%)
  • Afcons Infrastr.
    304.70 479.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Phaarmasia Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 2597.0
  • ISIN : INE486I01016
86.20 -2 (-2.05%)
  • As on 15 Sep 2026 (EOD)

  • Today’s Low

    86.20

  • Today’s High

    88.85

  • Open

    88.85

  • Perv Close

    88.00

  • 52W Low

    30.01

  • 52W High

    131.75

Key Indicators

  • P/E(TTM)

    26.94

  • Mar.Cap (₹Cr.)

    58.87

  • Div & Yield %

    0.00

  • Book Value(₹)

    32.36

  • Debt-Equity Ratio

    -2.05

  • AGM Date

    11-Sep-2026

  • EPS

    3.20

  • P/E Ratio

    26.94

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    58.87

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    6.83

  • BV (₹)

    32.40

  • Sales( ₹ in Cr.)

    47.21

  • NP (in Cr.)

    -4.80

  • NP Var(%)

    -202.0

  • Div%

    0.0

  • CPS (₹)

    -6.70

  • EPS (₹)

    -7.00

  • Traded Value (₹ in Lakhs)

    58.87

  • 52 Week High

    131.75

  • 52 Week Low

    30.01

  • Price BSE

    86.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    58.87

  • P/C Ratio

    -12.80

  • P/E Ratio

    -12.20

  • Price Vs.BV

    -7.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 47.21 24.37 30.59 27.49 17.22 16.26
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 47.21 24.37 30.59 27.49 17.22 16.26
Other Income 19.95 0.75 0.66 0.52 0.47 0.89
Stock Adjustments -0.28 -1.08 -0.60 1.67 0.49 -2.09
Total Income 66.88 24.04 30.65 29.68 18.18 15.06
EXPENDITURE :            
Raw Materials 33.22 18.38 24.01 24.13 14.35 12.49
Power and Fuel Cost 1.00 0.72 0.77 0.73 0.53 0.58
Employee Cost 2.61 1.68 1.53 1.41 1.17 1.36
Other Manufacturing Expenses 5.38 2.96 2.86 2.73 1.97 2.29
Selling and Administration Expenses 2.85 1.57 1.66 1.71 1.43 -2.49
Miscellaneous Expenses 0.00 0.00 0.00 0.00 0.00 0.00
Employee Benefit Expenses 2.61 1.68 1.53 1.41 1.17 1.36
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 45.05 25.30 30.82 30.71 19.44 14.23
Operating Profit 21.82 -1.26 -0.16 -1.03 -1.27 0.83
Interest 0.22 0.02 0.04 0.04 0.00 0.01
Gross Profit 21.60 -1.28 -0.20 -1.07 -1.27 0.82
Depreciation 0.21 0.32 0.34 0.36 0.29 0.34
Profit Before Tax 21.39 -1.60 -0.54 -1.43 -1.56 0.48
Current Tax 3.71 0.00 0.00 0.00 0.00 0.18
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.10 -0.01 -0.03 -0.17 -0.02 -0.02
Reported Net Profit 17.57 -1.59 -0.52 -1.26 -1.55 0.31
Extraordinary Items 22.37 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit -4.80 -1.59 -0.52 -1.26 -1.55 0.31
Adjustment below Net Profit 0.00 0.03 0.01 -0.01 0.31 0.00
P & L Balance brought forward -3.11 -1.51 -1.00 0.28 1.51 1.51
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 14.47 -3.07 -1.51 -1.00 0.28 1.82
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 25.74 -2.33 -0.76 -1.84 -2.27 0.46
Earnings Per Share(Adj)-Unit Curr 25.74 -2.33 -0.76 -1.84 -2.27 0.46
Book Value 32.37 6.58 8.87 9.62 11.45 13.79
Book Value(Adj)-Unit Curr 32.37 6.58 8.87 9.62 11.45 13.79

Shareholding Pattern

  • Promoter Group

    73.51%

  • Public Share Holding

    26.49%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 5,018,732 73.51 5,018,732 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,018,732 73.51 5,018,732 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 240 0.00 0 3
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,720 0.05 0 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,960 0.06 0 7
2] Non Institution
Bodies Corporate 10,159 0.15 5,708 61
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 17,176 0.25 17,176 17
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 24,288 0.36 24,288 33
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 539,975 7.91 539,975 6
Individuals holding nominal share capital up to Rs. 1 lakh 1,212,546 17.76 387,180 20,158
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,804,268 26.43 974,451 20,277
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,826,960 100.00 5,993,183 20,286

Company Background

Phaarmasia LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Phaarmasia Ltd
  • BSE Code : 2597.0
  • ISIN : INE486I01016

  • Incorporation Year

    1981

  • Registered Office

    16 Phase III
    I D A Jeedimetla, Hyderabad,
    Telangana-500055

  • Telephone

    91-40-23095002/23095690

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Urvashi Bhatia

  • Auditor

    Sathuluri & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Phaarmasia Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Phaarmasia 86.20 48.17 47.21 3.34 18.60
Abbott India 25,586.10 7,217.19 6,929.05 33.67 43.78
Astrazeneca Phar 6,785.35 2,304.07 2,275.58 100.01 27.86
Glaxosmi. Pharma 2,837.20 3,932.76 3,790.20 45.32 58.17
Novartis India 2,393.15 393.10 354.33 60.43 15.94
Cipla 1,365.00 20,102.60 18,979.95 35.87 13.88
Bliss GVS Pharma 722.45 773.53 729.81 67.14 12.51
Amrutanjan Healt 490.35 520.13 502.55 26.26 24.16
Fermenta Biotec. 475.05 474.15 450.25 22.18 18.77
Guj. Themis Bio. 423.35 168.25 165.82 113.20 18.05
Ambalal Sarabhai 40.61 19.52 3.94 75.20 6.77